Comparing Intensity-Modulated Proton Therapy With Intensity-Modulated Photon Therapy for Oropharyngeal Cancer: The Journey From Clinical Trial Concept to Activation

Steven J. Frank; Pierre Blanchard; J. Jack Lee; Erich M. Sturgis; Merrill S. Kies; Mitchell Machtay; Bhadrasain Vikram; Adam S. Garden; David I. Rosenthal; G. Brandon Gunn; C. David Fuller; Katherine Hutcheson; Stephen Lai; Paul M. Busse; Nancy Y. Lee; Alexander Lin; Robert L. Foote

doi:10.1016/j.semradonc.2017.12.002

Comparing Intensity-Modulated Proton Therapy With Intensity-Modulated Photon Therapy for Oropharyngeal Cancer: The Journey From Clinical Trial Concept to Activation

Steven J. Frank, Pierre Blanchard, J. Jack Lee, Erich M. Sturgis, Merrill S. Kies, Mitchell Machtay, Bhadrasain Vikram, Adam S. Garden, David I. Rosenthal, G. Brandon Gunn, C. David Fuller, Katherine Hutcheson, Stephen Lai, Paul M. Busse, Nancy Y. Lee, Alexander Lin, Robert L. Foote

Résultats de recherche: Contribution à un journal › Article 'review' › Revue par des pairs

27 Citations (Scopus)

Résumé

Intensity-modulated proton therapy minimizes the incidental irradiation of normal tissues in patients with head and neck cancer relative to intensity-modulated photon (x-ray) therapy and has been associated with lesser treatment-related toxicity and improved quality of life. A phase II/III randomized trial sponsored by the US National Cancer Institute is currently underway to compare deintensification treatment strategies with intensity-modulated proton therapy vs intensity-modulated photon (x-ray) therapy for patients with advanced-stage oropharyngeal tumors. After significant input from numerous stakeholders, the phase III portion of the randomized trial was redesigned as a noninferiority trial with progression-free survival as the primary endpoint. The process by which that redesign took place is described here.

langue originale	Anglais
Pages (de - à)	108-113
Nombre de pages	6
journal	Seminars in Radiation Oncology
Volume	28
Numéro de publication	2
Les DOIs	https://doi.org/10.1016/j.semradonc.2017.12.002
état	Publié - 1 avr. 2018

Accès au document

10.1016/j.semradonc.2017.12.002

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

Frank, S. J., Blanchard, P., Lee, J. J., Sturgis, E. M., Kies, M. S., Machtay, M., Vikram, B., Garden, A. S., Rosenthal, D. I., Gunn, G. B., Fuller, C. D., Hutcheson, K., Lai, S., Busse, P. M., Lee, N. Y., Lin, A., & Foote, R. L. (2018). Comparing Intensity-Modulated Proton Therapy With Intensity-Modulated Photon Therapy for Oropharyngeal Cancer: The Journey From Clinical Trial Concept to Activation. Seminars in Radiation Oncology, 28(2), 108-113. https://doi.org/10.1016/j.semradonc.2017.12.002

@article{74ec57a01b514f76892c578826b20b99,

title = "Comparing Intensity-Modulated Proton Therapy With Intensity-Modulated Photon Therapy for Oropharyngeal Cancer: The Journey From Clinical Trial Concept to Activation",

abstract = "Intensity-modulated proton therapy minimizes the incidental irradiation of normal tissues in patients with head and neck cancer relative to intensity-modulated photon (x-ray) therapy and has been associated with lesser treatment-related toxicity and improved quality of life. A phase II/III randomized trial sponsored by the US National Cancer Institute is currently underway to compare deintensification treatment strategies with intensity-modulated proton therapy vs intensity-modulated photon (x-ray) therapy for patients with advanced-stage oropharyngeal tumors. After significant input from numerous stakeholders, the phase III portion of the randomized trial was redesigned as a noninferiority trial with progression-free survival as the primary endpoint. The process by which that redesign took place is described here.",

author = "Frank, {Steven J.} and Pierre Blanchard and Lee, {J. Jack} and Sturgis, {Erich M.} and Kies, {Merrill S.} and Mitchell Machtay and Bhadrasain Vikram and Garden, {Adam S.} and Rosenthal, {David I.} and Gunn, {G. Brandon} and Fuller, {C. David} and Katherine Hutcheson and Stephen Lai and Busse, {Paul M.} and Lee, {Nancy Y.} and Alexander Lin and Foote, {Robert L.}",

note = "Publisher Copyright: {\textcopyright} 2018 The Authors",

year = "2018",

month = apr,

day = "1",

doi = "10.1016/j.semradonc.2017.12.002",

language = "English",

volume = "28",

pages = "108--113",

journal = "Seminars in Radiation Oncology",

issn = "1053-4296",

number = "2",

}

Frank, SJ, Blanchard, P, Lee, JJ, Sturgis, EM, Kies, MS, Machtay, M, Vikram, B, Garden, AS, Rosenthal, DI, Gunn, GB, Fuller, CD, Hutcheson, K, Lai, S, Busse, PM, Lee, NY, Lin, A & Foote, RL 2018, 'Comparing Intensity-Modulated Proton Therapy With Intensity-Modulated Photon Therapy for Oropharyngeal Cancer: The Journey From Clinical Trial Concept to Activation', Seminars in Radiation Oncology, VOL. 28, Numéro 2, p. 108-113. https://doi.org/10.1016/j.semradonc.2017.12.002

Comparing Intensity-Modulated Proton Therapy With Intensity-Modulated Photon Therapy for Oropharyngeal Cancer: The Journey From Clinical Trial Concept to Activation. / Frank, Steven J.; Blanchard, Pierre; Lee, J. Jack et al.
Dans: Seminars in Radiation Oncology, Vol 28, Numéro 2, 01.04.2018, p. 108-113.

Résultats de recherche: Contribution à un journal › Article 'review' › Revue par des pairs

TY - JOUR

T1 - Comparing Intensity-Modulated Proton Therapy With Intensity-Modulated Photon Therapy for Oropharyngeal Cancer

T2 - The Journey From Clinical Trial Concept to Activation

AU - Frank, Steven J.

AU - Blanchard, Pierre

AU - Lee, J. Jack

AU - Sturgis, Erich M.

AU - Kies, Merrill S.

AU - Machtay, Mitchell

AU - Vikram, Bhadrasain

AU - Garden, Adam S.

AU - Rosenthal, David I.

AU - Gunn, G. Brandon

AU - Fuller, C. David

AU - Hutcheson, Katherine

AU - Lai, Stephen

AU - Busse, Paul M.

AU - Lee, Nancy Y.

AU - Lin, Alexander

AU - Foote, Robert L.

PY - 2018/4/1

Y1 - 2018/4/1

N2 - Intensity-modulated proton therapy minimizes the incidental irradiation of normal tissues in patients with head and neck cancer relative to intensity-modulated photon (x-ray) therapy and has been associated with lesser treatment-related toxicity and improved quality of life. A phase II/III randomized trial sponsored by the US National Cancer Institute is currently underway to compare deintensification treatment strategies with intensity-modulated proton therapy vs intensity-modulated photon (x-ray) therapy for patients with advanced-stage oropharyngeal tumors. After significant input from numerous stakeholders, the phase III portion of the randomized trial was redesigned as a noninferiority trial with progression-free survival as the primary endpoint. The process by which that redesign took place is described here.

AB - Intensity-modulated proton therapy minimizes the incidental irradiation of normal tissues in patients with head and neck cancer relative to intensity-modulated photon (x-ray) therapy and has been associated with lesser treatment-related toxicity and improved quality of life. A phase II/III randomized trial sponsored by the US National Cancer Institute is currently underway to compare deintensification treatment strategies with intensity-modulated proton therapy vs intensity-modulated photon (x-ray) therapy for patients with advanced-stage oropharyngeal tumors. After significant input from numerous stakeholders, the phase III portion of the randomized trial was redesigned as a noninferiority trial with progression-free survival as the primary endpoint. The process by which that redesign took place is described here.

UR - http://www.scopus.com/inward/record.url?scp=85041624949&partnerID=8YFLogxK

U2 - 10.1016/j.semradonc.2017.12.002

DO - 10.1016/j.semradonc.2017.12.002

M3 - Review article

C2 - 29735186

AN - SCOPUS:85041624949

SN - 1053-4296

VL - 28

SP - 108

EP - 113

JO - Seminars in Radiation Oncology

JF - Seminars in Radiation Oncology

IS - 2

ER -